Cargando…
Diverging fates of cells of origin in acute and chronic leukaemia
The large difference in phenotypes among tumour populations may stem from the stochastic origin of tumours from distinct cells – tumour cells are assumed to retain the phenotypes of the cells from which they derive. Yet, functional studies addressing the cellular origin of leukaemia are lacking. Her...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376859/ https://www.ncbi.nlm.nih.gov/pubmed/22323443 http://dx.doi.org/10.1002/emmm.201100208 |
_version_ | 1782235884385468416 |
---|---|
author | Kovacic, Boris Hoelbl, Andrea Litos, Gabriele Alacakaptan, Memetcan Schuster, Christian Fischhuber, Katrin M Kerenyi, Marc A Stengl, Gabriele Moriggl, Richard Sexl, Veronika Beug, Hartmut |
author_facet | Kovacic, Boris Hoelbl, Andrea Litos, Gabriele Alacakaptan, Memetcan Schuster, Christian Fischhuber, Katrin M Kerenyi, Marc A Stengl, Gabriele Moriggl, Richard Sexl, Veronika Beug, Hartmut |
author_sort | Kovacic, Boris |
collection | PubMed |
description | The large difference in phenotypes among tumour populations may stem from the stochastic origin of tumours from distinct cells – tumour cells are assumed to retain the phenotypes of the cells from which they derive. Yet, functional studies addressing the cellular origin of leukaemia are lacking. Here we show that the cells of origin of both, BCR/ABL-induced chronic myeloid (CML) and B-cell acute lymphoid leukaemia (B-ALL), resemble long-term haematopoietic stem cells (LT-HSCs). During disease-maintenance, CML LT-HSCs persist to function as cancer stem cells (CSCs) that maintain leukaemia and require signalling by the transcription factor STAT5. In contrast, B-ALL LT-HSCs differentiate into CSCs that correspond to pro-B cells. This transition step requires a transient IL-7 signal and is lost in IL-7Rα-deficient cells. Thus, in BCR/ABLp185(+) B-ALL and BCR/ABLp210(+) CML, the final phenotype of the tumour as well as the abundance of CSCs is dictated by diverging differentiation fates of their common cells of origin. |
format | Online Article Text |
id | pubmed-3376859 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | WILEY-VCH Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-33768592012-09-17 Diverging fates of cells of origin in acute and chronic leukaemia Kovacic, Boris Hoelbl, Andrea Litos, Gabriele Alacakaptan, Memetcan Schuster, Christian Fischhuber, Katrin M Kerenyi, Marc A Stengl, Gabriele Moriggl, Richard Sexl, Veronika Beug, Hartmut EMBO Mol Med Research Article The large difference in phenotypes among tumour populations may stem from the stochastic origin of tumours from distinct cells – tumour cells are assumed to retain the phenotypes of the cells from which they derive. Yet, functional studies addressing the cellular origin of leukaemia are lacking. Here we show that the cells of origin of both, BCR/ABL-induced chronic myeloid (CML) and B-cell acute lymphoid leukaemia (B-ALL), resemble long-term haematopoietic stem cells (LT-HSCs). During disease-maintenance, CML LT-HSCs persist to function as cancer stem cells (CSCs) that maintain leukaemia and require signalling by the transcription factor STAT5. In contrast, B-ALL LT-HSCs differentiate into CSCs that correspond to pro-B cells. This transition step requires a transient IL-7 signal and is lost in IL-7Rα-deficient cells. Thus, in BCR/ABLp185(+) B-ALL and BCR/ABLp210(+) CML, the final phenotype of the tumour as well as the abundance of CSCs is dictated by diverging differentiation fates of their common cells of origin. WILEY-VCH Verlag 2012-04 /pmc/articles/PMC3376859/ /pubmed/22323443 http://dx.doi.org/10.1002/emmm.201100208 Text en Copyright © 2012 EMBO Molecular Medicine |
spellingShingle | Research Article Kovacic, Boris Hoelbl, Andrea Litos, Gabriele Alacakaptan, Memetcan Schuster, Christian Fischhuber, Katrin M Kerenyi, Marc A Stengl, Gabriele Moriggl, Richard Sexl, Veronika Beug, Hartmut Diverging fates of cells of origin in acute and chronic leukaemia |
title | Diverging fates of cells of origin in acute and chronic leukaemia |
title_full | Diverging fates of cells of origin in acute and chronic leukaemia |
title_fullStr | Diverging fates of cells of origin in acute and chronic leukaemia |
title_full_unstemmed | Diverging fates of cells of origin in acute and chronic leukaemia |
title_short | Diverging fates of cells of origin in acute and chronic leukaemia |
title_sort | diverging fates of cells of origin in acute and chronic leukaemia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376859/ https://www.ncbi.nlm.nih.gov/pubmed/22323443 http://dx.doi.org/10.1002/emmm.201100208 |
work_keys_str_mv | AT kovacicboris divergingfatesofcellsoforigininacuteandchronicleukaemia AT hoelblandrea divergingfatesofcellsoforigininacuteandchronicleukaemia AT litosgabriele divergingfatesofcellsoforigininacuteandchronicleukaemia AT alacakaptanmemetcan divergingfatesofcellsoforigininacuteandchronicleukaemia AT schusterchristian divergingfatesofcellsoforigininacuteandchronicleukaemia AT fischhuberkatrinm divergingfatesofcellsoforigininacuteandchronicleukaemia AT kerenyimarca divergingfatesofcellsoforigininacuteandchronicleukaemia AT stenglgabriele divergingfatesofcellsoforigininacuteandchronicleukaemia AT morigglrichard divergingfatesofcellsoforigininacuteandchronicleukaemia AT sexlveronika divergingfatesofcellsoforigininacuteandchronicleukaemia AT beughartmut divergingfatesofcellsoforigininacuteandchronicleukaemia |